Cationic liposomes

Thomas Lars Andresen (Inventor), Simon Skjøde Jensen (Inventor), Jonas Rosager Henriksen (Inventor), Ladan Parhamifar (Inventor), Rasmus Mikkel Münter Lassen (Inventor)

Research output: Patent

321 Downloads (Pure)


Disclosed herein are cationic liposomes suitable for specific delivery of immunomodulating agents to monocytes and dendritic cells. The cationic liposomes comprise phospholipids, cholesterol, cationic lipids, PEG and at least one active ingredient and have a zeta potential in the range of 13-25 mV. Further disclosed are uses of such cationic liposomes in various pharmaceutical applications.
Original languageEnglish
IPCA61K31/522; A61K39/39; A61K47/02; A61K47/69; A61K9/127; A61P35/00
Patent numberWO2019012107
Filing date17/01/2019
Country/TerritoryInternational Bureau of the World Intellectual Property Organization (WIPO)
Priority date13/07/2017
Priority numberEP20170181122
Publication statusPublished - 2019


Dive into the research topics of 'Cationic liposomes'. Together they form a unique fingerprint.

Cite this